Integrin Alpha(V)Beta(6) For Diagnosis/Prognosis Of Colorectal Carcinoma

Patent No. EP2979096 (titled "Integrin Alpha(V)Beta(6) For Diagnosis/Prognosis Of Colorectal Carcinoma") was filed by Universitt Zrich on Mar 27, 2014. The application was issued on May 10, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MERCK PATENTFeb 12, 2018-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2979096

UNIVERSITT ZRICH
Application Number
EP14712691A
Filing Date
Mar 27, 2014
Status
Revoked
Jan 4, 2019
Publication Date
May 10, 2017